Heavy Periods: When to See a Doctor

What Counts as a "Heavy" Period

A period becomes clinically heavy when total blood loss exceeds 80 mL per cycle, but measuring volume at home is impractical. Doctors instead rely on symptom-based criteria that any patient can track without special equipment.

The American College of Obstetricians and Gynecologists (ACOG) defines heavy menstrual bleeding (HMB) as bleeding that soaks through one or more pads or tampons every hour for several consecutive hours, passage of blood clots equal to or larger than a quarter, bleeding lasting longer than seven days, or bleeding heavy enough to restrict daily activities [1]. The Pictorial Blood Loss Assessment Chart (PBAC), a validated scoring tool, assigns points based on the degree of saturation of pads and tampons plus clot size. A PBAC score above 100 correlates with measured blood loss exceeding the 80 mL threshold [2]. Night-time flooding that forces waking to change protection also qualifies. If you regularly double up on pads and tampons at the same time, that alone signals above-normal flow.

Not every heavy cycle signals pathology. A single unusually heavy period can follow a delayed ovulation, stress, or travel. The pattern matters. Two or more consecutive cycles meeting HMB criteria should prompt a visit to a clinician. Women who have always bled heavily since menarche may carry an undiagnosed bleeding disorder, a possibility explored later in this article [3].

When Heavy Bleeding Becomes an Emergency

Some bleeding patterns require same-day or emergency evaluation. Saturating a pad in under 30 minutes, feeling faint or lightheaded while bleeding, or a heart rate above 100 bpm at rest during menses can indicate acute blood loss anemia.

The hemoglobin drop does not always match what the patient perceives. A 2019 retrospective study in Obstetrics & Gynecology found that 26% of women presenting to the emergency department for acute abnormal uterine bleeding had hemoglobin levels below 8 g/dL, the typical threshold for considering transfusion [4]. Orthostatic hypotension (a systolic blood pressure drop of 20 mmHg or more upon standing) during heavy bleeding is another red flag that warrants urgent care.

Postmenopausal bleeding is a separate category entirely. Any vaginal bleeding occurring 12 months or more after the final menstrual period must be evaluated to rule out endometrial cancer, regardless of volume [5]. The evaluation is straightforward: transvaginal ultrasound to measure endometrial thickness, often followed by endometrial biopsy if the stripe measures 4 mm or greater.

Why Periods Become Heavy: The Major Causes

The International Federation of Gynecology and Obstetrics (FIGO) classifies causes of abnormal uterine bleeding using the PALM-COEIN system, a mnemonic dividing etiologies into structural (Polyp, Adenomyosis, Leiomyoma, Malignancy) and non-structural (Coagulopathy, Ovulatory dysfunction, Endometrial, Iatrogenic, Not yet classified) categories [6].

Structural Causes

Uterine fibroids (leiomyomas) are the single most common structural cause. They affect up to 70% of white women and over 80% of Black women by age 50 [7]. Submucosal fibroids, those protruding into the uterine cavity, produce the heaviest bleeding even when small. A 2-cm submucosal fibroid can cause more bleeding than a 10-cm intramural fibroid located within the wall.

Endometrial polyps occur in 10-40% of women with abnormal bleeding. Most are benign, but the malignancy risk rises after age 60 and in women on tamoxifen therapy [8].

Adenomyosis, where endometrial-type tissue invades the uterine muscle, produces both heavy bleeding and severe cramping. MRI is the gold standard for diagnosis, though transvaginal ultrasound by an experienced sonographer can detect classic signs like an asymmetrically enlarged uterus with heterogeneous myometrium [9].

Non-Structural Causes

Ovulatory dysfunction is common at the extremes of reproductive life: the first two years after menarche and the perimenopause. Anovulatory cycles lack the progesterone-driven organization of the endometrium, leading to irregular, sometimes torrential shedding.

Bleeding disorders are underdiagnosed. Von Willebrand disease (VWD) affects approximately 1% of the general population, but prevalence among women presenting with HMB runs between 5% and 24% [10]. ACOG recommends screening for underlying bleeding disorders in any adolescent with heavy periods from menarche and in any adult whose HMB has not responded to standard treatment.

Thyroid dysfunction, particularly hypothyroidism, can increase menstrual flow by altering sex hormone-binding globulin levels and impairing coagulation factor metabolism. A simple TSH test can rule this in or out.

Iatrogenic causes include copper IUDs (which increase menstrual blood loss by 20-50% on average), anticoagulant medications like warfarin and rivaroxaban, and certain antidepressants that affect serotonin-mediated platelet function [11].

The HealthRX 3-Layer Triage Framework for Heavy Bleeding

Not every case of heavy bleeding carries the same urgency. This decision framework helps patients and clinicians categorize bleeding severity into action tiers.

Layer 1: Urgent (act within hours). Soaking more than one pad per 30 minutes for two or more hours. Hemoglobin known or suspected to be below 8 g/dL. Syncope, near-syncope, or resting tachycardia above 110 bpm. Action: emergency department evaluation, IV access, type-and-screen, consider tranexamic acid 1 g IV.

Layer 2: Soon (act within one to two weeks). Consistent soaking of one pad per hour for two or more hours per cycle over two or more cycles. Clots larger than a quarter. Fatigue worsening month over month. Action: schedule gynecology visit, obtain CBC with ferritin, TSH, and coagulation screen before the appointment.

Layer 3: Monitor (act within one to three months). Single episode of heavier-than-usual bleeding with no hemodynamic symptoms. Periods lasting seven to eight days without other red flags. Action: track three cycles using a period-tracking app or PBAC chart, then reassess. If the pattern persists, escalate to Layer 2.

This three-tier structure allows patients to self-screen before deciding whether to call their doctor today or schedule a routine visit.

How Doctors Diagnose the Cause

The diagnostic workup for heavy menstrual bleeding follows a logical sequence: history, labs, imaging, and, when needed, tissue sampling. Each step narrows the differential.

History and physical exam come first. The clinician will ask about cycle length, duration, pad or tampon usage, clot size, family history of bleeding disorders, and any medications. A speculum exam rules out cervical lesions, and a bimanual exam estimates uterine size and tenderness.

Laboratory tests typically include a complete blood count (CBC) to assess for anemia, serum ferritin (the earliest marker of iron depletion, often abnormal before hemoglobin drops), TSH, and a pregnancy test in reproductive-age women. If a bleeding disorder is suspected, a coagulation panel, von Willebrand factor antigen, ristocetin cofactor activity, and factor VIII level are ordered [12].

Transvaginal ultrasound (TVUS) is the first-line imaging study. It detects fibroids, polyps, adenomyosis, and endometrial thickening. Saline infusion sonohysterography (SIS), where sterile saline is instilled into the uterine cavity during ultrasound, improves detection of intracavitary lesions. A 2020 meta-analysis in Ultrasound in Obstetrics & Gynecology reported that SIS has a sensitivity of 95% and specificity of 88% for detecting endometrial polyps [13].

Endometrial biopsy is recommended for women aged 45 and older with HMB, for women under 45 who have risk factors for endometrial hyperplasia (obesity, chronic anovulation, tamoxifen use, family history of endometrial or colon cancer), and for any woman whose bleeding does not respond to initial medical therapy [14]. The procedure, performed in-office with a thin catheter (Pipelle), takes under 60 seconds and does not require anesthesia in most cases.

Hysteroscopy provides direct visualization of the uterine cavity. It is both diagnostic and therapeutic: polyps and small submucosal fibroids can be removed during the same procedure.

Iron Deficiency: The Silent Consequence

Heavy menstrual bleeding is the leading cause of iron deficiency anemia in premenopausal women worldwide. A 2023 cross-sectional study published in The Lancet Haematology found that 63% of women referred for HMB evaluation had ferritin levels below 30 ng/mL, the threshold the WHO uses to define iron depletion, and 33% met criteria for iron deficiency anemia with hemoglobin below 12 g/dL [15].

Symptoms of iron deficiency extend beyond fatigue. Brain fog, restless legs, pica (craving ice or non-food substances), hair thinning, and exercise intolerance can all stem from depleted iron stores. Many women attribute these symptoms to stress or aging and do not connect them to their periods.

Oral iron supplementation (ferrous sulfate 325 mg on alternate days) improves absorption and reduces gastrointestinal side effects compared with daily dosing, per a 2020 randomized trial in The Lancet Haematology [16]. For women with ferritin below 15 ng/mL, hemoglobin below 10 g/dL, or intolerance to oral iron, intravenous iron (ferric carboxymaltose 750 mg x 2 doses or iron sucrose) can replete stores in one to two infusions. Ferritin should be rechecked 8-12 weeks after repletion.

Treatment Options That Work

Treatment depends on the cause, the patient's reproductive plans, and symptom severity. NICE guideline NG88 (updated 2021) and ACOG Practice Bulletin No. 128 provide the evidence hierarchy below [17][18].

Medical Therapies

Levonorgestrel intrauterine system (LNG-IUS, Mirena). This is the single most effective medical treatment. The 52-mg LNG-IUS reduces menstrual blood loss by 71-95% within six months and is as effective as endometrial ablation or hysterectomy for quality-of-life improvement, with far fewer risks [19]. It works for five to eight years per device depending on the indication.

Tranexamic acid (Lysteda). An antifibrinolytic taken only during heavy bleeding days (1 to 300 mg three times daily for up to five days). It reduces flow by 26-54% and does not affect fertility or hormonal balance [20]. Contraindicated in patients with active thromboembolic disease.

Combined oral contraceptives. Reduce menstrual blood loss by 35-69%. The extended-cycle formulation (84 active pills followed by 7 placebo) limits the number of withdrawal bleeds to four per year. This approach works well for women who also need contraception.

Oral progestins. Norethindrone acetate 5 mg daily (cyclical, days 5-26) or medroxyprogesterone acetate 10 mg daily for 10-14 days per cycle can regulate anovulatory bleeding. Long-term continuous progestins cause endometrial atrophy, reducing flow substantially.

GnRH agonists and antagonists. Elagolix (Orilissa) and relugolix combination therapy (Myfembree) are FDA-approved for fibroid-associated HMB. Myfembree reduced HMB to normal levels in 73% of women at 24 weeks in the LIBERTY 1 trial (N=388) vs. 29% with placebo [21].

Surgical Therapies

Hysteroscopic polypectomy or myomectomy. For submucosal fibroids (FIGO type 0 or 1) and polyps, outpatient hysteroscopic resection resolves bleeding in 60-90% of cases without affecting future fertility [22].

Endometrial ablation. Second-generation techniques (NovaSure radiofrequency, Thermachoice balloon) destroy the endometrial lining. Amenorrhea rates range from 35-55% at one year; satisfaction rates exceed 85% at five years. This procedure is only for women who have completed childbearing, as pregnancy after ablation carries serious risks [23].

Uterine artery embolization (UAE). Interventional radiology procedure that blocks blood flow to fibroids. A Cochrane review found similar symptom relief compared with surgery at two years, with shorter recovery but higher reintervention rates [24].

Hysterectomy. The definitive treatment. Indicated when medical management fails, when fibroids are very large or numerous, or when malignancy is present. Minimally invasive approaches (laparoscopic, robotic, vaginal) are preferred and offer recovery in two to four weeks [25].

Tracking Your Bleeding Before Your Appointment

Arriving at your first appointment with objective data accelerates diagnosis. Track at least two full cycles. Record the number of pads or tampons used per day, the degree of saturation (light, moderate, soaked through), the number and approximate size of clots, any associated symptoms (cramping, dizziness, fatigue), and the total duration of bleeding.

Free period-tracking apps can automate most of this. Some clinics provide a printed PBAC chart to fill in. Bringing this data means your clinician can quantify severity at the first visit rather than ordering a follow-up just to establish a baseline.

The ACOG Committee Opinion on menstrual health recommends that clinicians treat the menstrual cycle as a "vital sign" in adolescents and adults, screening for abnormalities at every well-woman visit [26]. If your provider does not ask about your periods, bring it up.

Special Populations

Adolescents. Up to 20% of adolescents with HMB from menarche have an underlying bleeding disorder. The initial evaluation should include VWD testing before attributing heavy periods to "just hormones settling in" [27].

Perimenopause. Fluctuating estrogen and declining progesterone make erratic, heavy cycles common in the 40s. Endometrial biopsy is recommended more liberally in this age group because the incidence of endometrial hyperplasia and carcinoma begins to rise [28].

Women on anticoagulants. Warfarin, direct oral anticoagulants (rivaroxaban, apixaban), and antiplatelet agents all increase menstrual blood loss. Tranexamic acid can be used concurrently in many cases after hematology consultation. The LNG-IUS is effective and safe in anticoagulated patients [29].

Women with obesity. BMI above 30 independently increases the risk of anovulatory HMB and endometrial hyperplasia due to peripheral aromatization of androgens to estrogen in adipose tissue. Weight management, combined with progestin therapy, addresses both the symptom and the underlying endometrial risk [30].

What to Ask Your Doctor

Prepare specific questions before your appointment. Consider asking: "Have you checked my ferritin level, not just my hemoglobin?" Ferritin drops before hemoglobin does. Ask whether a saline sonogram would add value beyond a standard ultrasound, especially if initial imaging is normal. Ask about von Willebrand disease testing if your bleeding has been heavy since your first period. Ask whether a levonorgestrel IUD could treat both your bleeding and provide contraception simultaneously.

Patients who advocate with data and targeted questions tend to reach a diagnosis faster. According to a 2018 survey published in the American Journal of Obstetrics and Gynecology, the median time from symptom onset to HMB diagnosis was 16 months, a delay largely driven by normalization of symptoms by both patients and providers [31].

A ferritin level below 30 ng/mL in a menstruating woman with heavy periods should trigger iron repletion, even if hemoglobin remains within the normal reference range.